Biyoteknoloji Hisseleri — AI Analizi ve Sıralamaları
Bu sayfa İngilizce aslından yapay zekâ ile çevrildi; İngilizce sürüm esastır. İngilizce sürümü oku
Kısa Cevap
Yapay zeka destekli analiz, MoonshotScores ve fiyat hedefleri ile tüm Biyoteknoloji hisselerine göz atın.
Yapay zeka destekli analiz, MoonshotScores ve fiyat hedefleri ile tüm Biyoteknoloji hisselerine göz atın.
Biyoteknoloji içindeki İlgili Hisseler
| Şirket | Fiyat | Değişim | Piyasa Değeri | MoonshotScore |
|---|---|---|---|---|
| EXEL Exelixis, Inc. | $58.85 | +0.79% | $14.8B | — |
| HRMY Harmony Biosciences Holdings, Inc. | $39.92 | +0.71% | $2.31B | — |
| INCY Incyte Corporation | $113.81 | -1.29% | $23.1B | — |
| KRYS Krystal Biotech, Inc. | $322.28 | -0.93% | $9.50B | — |
| ARGX argenx SE | $919.21 | -1.79% | $57.2B | — |
| AUPH Aurinia Pharmaceuticals Inc. | $15.72 | -0.69% | $2.02B | — |
| ETON Eton Pharmaceuticals, Inc. | $55.62 | +0.47% | $1.52B | — |
| HALO Halozyme Therapeutics, Inc. | $108.53 | -1.22% | $12.9B | — |
| UTHR United Therapeutics Corporation | $536.40 | -0.98% | $22.8B | — |
| VRTX Vertex Pharmaceuticals Incorporated | $504.73 | -0.40% | $128B | — |
| LGND Ligand Pharmaceuticals Incorporated | $306.77 | +1.26% | $6.15B | — |
| VCYT Veracyte, Inc. | $46.52 | +1.55% | $3.71B | — |
| INVA Innoviva, Inc. | $20.50 | -0.24% | $1.51B | — |
| TBPH Theravance Biopharma, Inc. | $17.03 | — | $883M | — |
| ADMA ADMA Biologics, Inc. | $10.11 | +4.01% | $2.34B | — |
| CRMD CorMedix Inc. | $7.27 | +1.17% | $571M | — |
| REGN Regeneron Pharmaceuticals, Inc. | $726.94 | -1.12% | $74.9B | — |
| RIGL Rigel Pharmaceuticals, Inc. | $47.79 | +1.36% | $884M | — |
| TECH Bio-Techne Corporation | $72.58 | +0.25% | $11.4B | — |
| LQDA Liquidia Corporation | $27.11 | -5.32% | $2.41B | — |
| NBIX Neurocrine Biosciences, Inc. | $144.21 | +0.72% | $14.5B | — |
| VCEL Vericel Corporation | $41.07 | +2.29% | $2.10B | — |
| CORT Corcept Therapeutics Incorporated | $121.38 | +4.43% | $13.1B | — |
| NVO Novo Nordisk A/S | $37.32 | -0.21% | $166B | — |
| ZVRA Zevra Therapeutics, Inc. | $10.70 | +7.11% | $633M | — |
| ALNY Alnylam Pharmaceuticals, Inc. | $219.72 | -4.96% | $29.4B | — |
| CAI Caris Life Sciences, Inc. | $30.20 | +6.70% | $8.54B | — |
| ARQT Arcutis Biotherapeutics, Inc. | $25.15 | -0.04% | $3.15B | — |
| ASND Ascendis Pharma A/S | $228.03 | +0.07% | $14.2B | — |
| MDXG MiMedx Group, Inc. | $4.59 | -1.08% | $669M | — |
| ABUS Arbutus Biopharma Corporation | $4.67 | +4.94% | $923M | — |
| RLYB Rallybio Corporation | $16.90 | -1.05% | $89.7M | — |
| ANAB AnaptysBio, Inc. | $49.20 | +1.38% | $1.46B | — |
| ICCC ImmuCell Corporation | $9.75 | — | $88.2M | — |
| PHAR Pharming Group N.V. | $9.80 | +0.51% | $694M | — |
| ACAD ACADIA Pharmaceuticals Inc. | $20.11 | +0.80% | $3.44B | — |
| ORMP Oramed Pharmaceuticals Inc. | $4.55 | +1.34% | $186M | — |
| PTGX Protagonist Therapeutics, Inc. | $141.19 | +0.81% | $9.08B | — |
| ELVN Enliven Therapeutics, Inc. | $45.47 | -3.19% | $3.25B | — |
| PLX Protalix BioTherapeutics, Inc. | $2.71 | — | $218M | — |
| RPRX Royalty Pharma plc | $56.66 | -0.87% | $25.1B | — |
| MBX MBX Biosciences | $58.73 | +0.38% | $2.80B | — |
| BLTE Belite Bio, Inc. | $159.73 | +0.11% | $6.40B | — |
| LBRX LB Pharmaceuticals Inc | $34.62 | -6.41% | $993M | — |
| CLYM Climb Bio, Inc. | $11.05 | +1.01% | $633M | — |
| NAGE Niagen Bioscience Inc | $2.68 | -3.94% | $213M | — |
| ORKA Oruka Therapeutics, Inc. | $84.38 | -0.17% | $5.09B | — |
| ANTX AN2 Therapeutics, Inc. | $5.61 | -1.75% | $202M | — |
| QTTB Q32 Bio Inc. | $8.37 | +1.70% | $249M | — |
| AMLX Amylyx Pharmaceuticals, Inc. | $27.48 | -1.12% | $3.06B | — |
AI Skoru: Stock Expert AI · Fiyat verisi: FMP / Yahoo Finance